Table 1 Characteristics of RP and BT patients
RP (n = 737) | BT (n = 106) | P value | |
|---|---|---|---|
Age(years) | 69.0 (64.0–75.0) | 78.00 (72.0–81.0) | < 0.001 |
tPSA(ng/ml) | 11.28 (7.32–19.03) | 12.13 (7.09–25.89) | 0.173 |
Gleason score(%) | 0.426 | ||
6 | 174 (23.6%) | 22 (20.8%) | |
7 | 266 (36.1%) | 34 (32.1%) | |
8 | 146 (19.8%) | 31 (29.2%) | |
9 | 131 (17.8%) | 16 (15.1%) | |
10 | 20 (2.7%) | 3 (2.8%) | |
PPB | 0.42 (0.25–0.58) | 0.44 (0.25–0.67) | 0.089 |
Clinical T stage (%) | 0.003 | ||
T1 | 28 (3.8%) | 5 (4.7%) | |
T2 | 461 (62.6%) | 81 (76.4%) | |
T3 | 248 (33.6%) | 20 (18.9%) | |
Charlson score (%) | 0.001 | ||
0 | 542 (73.5%) | 64 (60.4%) | |
1 | 162 (22.0%) | 27 (25.5%) | |
2 | 24 (3.3%) | 13 (12.3%) | |
3 | 8 (1.1%) | 1 (0.9%) | |
4 | 1 (0.1%) | 1 (0.9%) | |
D’Amico risk (%) | < 0.001 | ||
Low | 26 (3.5%) | 13 (12.3%) | |
Intermediate | 118 (16.0%) | 29 (27.4%) | |
High | 593 (80.5%) | 64 (60.4%) |